Medipredict

What Medipredict does

Medipredict Kft. is a privately held Hungarian digital health company founded in 2016 and headquartered in Budapest, with a secondary office in Zürich, Switzerland. The company operates a multi-omic integrative health analysis platform that combines full genome sequencing, blood and urine metabolomics, gut microbiome metagenomics, epigenetic biological-age testing, environmental toxin mass spectrometry, and advanced imaging (full-body MRI and cardiac CT) into a single synthesized health profile. Its product architecture is organized as three core integrated reports (Integrált Egészségügyi Riport at HUF 6,950,000, Omika+ at HUF 2,950,000, and Omika at HUF 1,950,000) plus five standalone add-on modules priced between HUF 300,000 and HUF 1,450,000, with tiered bundle discounts of 5-20%.

The business model is sales-led direct-to-consumer, with a free initial consultation (Calendly) acting as the top-of-funnel, followed by high-touch, expert-led interpretation of results. Target customers are health-conscious high-net-worth individuals, people with family history of serious disease, and patients with chronic complaints lacking conventional diagnoses. Pricing, distribution, and customer profile are all consistent with a premium consumer health offering rather than an enterprise or insurance-integrated product. No external venture funding is disclosed for the Hungarian entity, and the company has not been the subject of M&A, partnership, or leadership changes in the available data. The company cites 25% of customers being identified with early-stage health deviations and a 98% reported satisfaction metric as commercial proof points.

Name

Medipredict

Legal name

Medipredict Kft.

Website

https://medipredict.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Preventive Health Diagnostics

NAICS

Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)

akta.pro primary industry

Population Genomics & Preventive Precision Health Programs (HLAAANAL)

akta.pro secondary industries

Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal) (HLAAAFAH), Pharmacogenomics-Informed Medication Optimization Support (HSABALAO)

Keywords

• Preventive health diagnostics
• Multi-omic health analysis
• Genomic testing services
• Personalized longevity medicine
• Biological age testing

Headquarters

HQ city

Budapest

HQ country

Hungary

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. One-Time Diagnostic Service Sales: Medipredict generates revenue through one-time purchases of premium diagnostic and health analysis services. Services range from individual tests (e.g., 300,000 Ft for Biological Age Test) to comprehensive integrated health reports (6,950,000 Ft). Customers select and purchase individual service packages or bundled offerings with volume discounts of 5–20%. The sales model involves initial free consultations followed by paid diagnostic services.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Medipredict sells premium personalized preventive health diagnostic packages that integrate full genome sequencing, gut microbiome metagenomic analysis, blood and urine metabolomics, epigenetic biological age testing, environmental toxin mass spectrometry, and advanced medical imaging (full-body MRI and cardiac CT). The company's proprietary algorithms and cross-disciplinary expert teams synthesize these multi-omic data streams into unified personalized health profiles, risk assessments, and tailored dietary, lifestyle, and pharmacological recommendations, delivered through expert-led consultations to individual consumers.

Product overview

Medipredict is a Hungarian longevity and preventive health company offering a platform-plus-modules product architecture. The core offerings are three integrated report products: Integrált Egészségügyi Riport (the most comprehensive, combining medical exams, lab work, imaging, and genetics), Omika+ (genome, microbiome, metabolome plus full-body MRI and cardiac CT), and Omika (genomic, microbiome, and metabolomic analysis without imaging). These are supplemented by five standalone add-on modules — Genetika Riport (full genome sequencing), Mikrobiom Riport (gut microbiome analysis), Metabolomika Riport (metabolite analysis), Biológiai Életkor Teszt (epigenetic biological age), and Környezeti Toxin Teszt (environmental toxin testing). Customers can purchase individual modules or combine them for discounts up to 20%.

Differentiator

Problem solved

Functional benefit

Brands

• Integrált Egészségügyi Riport: Premium service combining medical, genetic, microbiome, and metabolomics data analysis for comprehensive health profile.
• Omika+
• Omika
• Genetika
• Mikrobiom
• Metabolomika
• Biológiai Életkor Teszt
• Környezeti Toxin

Products and services

• Integrated Health Report (Integrált Egészségügyi Riport)
• Omika+ Report (Omika+ Riport)
• Omika Report (Omika Riport)
• Genetics Report (Genetika Riport)
• Microbiome Report (Mikrobiom Riport)
• Metabolomics Report (Metabolomika Riport)
• Biological Age Test (Biológiai Életkor Teszt)
• Environmental Toxin Test (Környezeti Toxin Teszt)

Quantifiable outcome

• 25% of customers identified early-stage deviations that could have led to serious illness without treatment
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature6 records

Partnerships

One partnership is on record.

• MediElaj (India)minorOthers · 12 May 2026A separate Indian healthcare technology company called MediElaj that also operates in the AI-powered diagnostic kiosk and app space in India, with partnerships with hospitals and colleges. Not to be confused with Medipredict (Hungary/Switzerland). Source appears to reference a Medipredict-related entity in India with separate operations.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Neko Health: Swedish preventive health startup offering AI-powered full-body scanning combined with blood-based diagnostics in a single premium membership. Most directly comparable European peer — both target health-conscious consumers with integrated, multi-modal preventive assessments priced at premium levels.
• Prenuvo: US-based preventive health platform offering whole-body MRI screening with blood biomarkers and AI-driven analysis, targeting similar affluent, longevity-focused consumers with premium pricing and D2C sales motion. Overlaps with Medipredict's Omika+ (full-body MRI + cardiac CT + multi-omic).
• Fountain Life: US premium longevity and preventive health company combining advanced imaging, full-body diagnostics, and AI-driven health assessments for high-net-worth individuals. Closely mirrors Medipredict's integrated multi-omic + imaging offering for the same executive/longevity segment.
• Function Health: US preventive health platform offering 100+ lab biomarkers plus whole-body MRI in a membership model for health-conscious consumers. Directly comparable in scope (multi-domain diagnostics), customer profile, and D2C premium positioning.
• Human Longevity Inc. Founded by Craig Venter, HLI combines whole-genome sequencing, advanced imaging, and AI-driven health intelligence for executive health programs. Closest competitor in terms of integrating full genomics with imaging for high-end preventive assessments.
• InsideTracker: Personalized health platform analyzing blood biomarkers, DNA, and lifestyle data to deliver actionable longevity and performance recommendations. Comparable D2C motion, multi-domain data integration, and target segment of health-optimization consumers.

Emerging players

• Viome Life Sciences: US-based microbiome and RNA analytics company offering gut microbiome testing with personalized nutrition recommendations. Overlaps with Medipredict's microbiome metagenomic module and recommendation engine.
• Superpower: US preventive health startup offering annual memberships bundling dozens of lab tests, whole-body MRI, and AI-driven health insights. Comparable scope to Medipredict's integrated report with a younger, membership-based commercial model.
• DayTwo: Israel-based microbiome and personalized nutrition platform using gut microbiome analysis for glycemic and metabolic personalization. Comparable microbiome-first analytical approach and recommendation engine to Medipredict's Mikrobiom Riport.

Broad incumbents

• 23andMe: US consumer genetics leader offering DTC genetic testing including health predispositions, carrier status, and pharmacogenomics — directly overlaps Medipredict's Genetics Report at lower price points and at massive scale.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@Medipredict
• Facebookfacebook.com/medipredicthealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medipredict